Castle Biosciences Medical Advisory Board (MAB) members have been involved in the development and publication of multiple Barrett’s esophagus (BE) and esophageal cancer (EC) guidelines, participated in major BE clinical and research initiatives, and have served on the editorial boards of major gastroenterology journals. Collectively the group has published hundreds of peer-reviewed journal articles and served as Principal Investigators on numerous clinical trials.
